Hypersensitivity  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT01588964: IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Completed
2
30
Europe
HIPEC, IPHC, Hypertermic intraperitoneal chemotherapy
Catholic University of the Sacred Heart
Ovarian Epithelial Cancer Recurrent
10/11
12/11
NCT01481701: A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Completed
2
90
Europe
Oxaliplatin, No other intervention, oxaliplatin
Jules Bordet Institute
Ovarian Carcinoma, Relapse
05/14
05/14

Download Options